Showing 1 - 20 results of 56 for search 'Arndt Borkhardt', query time: 0.04s Refine Results
  1. 1
    Trio sequencing in pediatric cancer and clinical implications

    Trio sequencing in pediatric cancer and clinical implications by Michaela Kuhlen, Arndt Borkhardt

    Published 2018-04-01
    Get full text
    Article
  2. 2
    Identification of TEL-AML1 (ETV6-RUNX1) associated DNA and its impact on mRNA and protein output using ChIP, mRNA expression arrays and SILAC

    Identification of TEL-AML1 (ETV6-RUNX1) associated DNA and its impact on mRNA and protein output using ChIP, mRNA expression arrays and SILAC by Yvonne Linka, Sebastian Ginzel, Arndt Borkhardt, Pablo Landgraf

    Published 2014-12-01
    Get full text
    Article
  3. 3
    Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry

    Temporal changes of the incidence of childhood cancer in Germany during the COVID-19 pandemic: Updated analyses from the German Childhood Cancer Registry by Friederike Erdmann, Claudia Spix, Martin Schrappe, Arndt Borkhardt, Joachim Schüz

    Published 2022-06-01
    Get full text
    Article
  4. 4
    The PARA-suite: PAR-CLIP specific sequence read simulation and processing

    The PARA-suite: PAR-CLIP specific sequence read simulation and processing by Andreas Kloetgen, Arndt Borkhardt, Jessica I. Hoell, Alice C. McHardy

    Published 2016-10-01
    Get full text
    Article
  5. 5
    The Microbiome in Childhood Acute Lymphoblastic Leukemia

    The Microbiome in Childhood Acute Lymphoblastic Leukemia by Marina Oldenburg, Nadine Rüchel, Stefan Janssen, Arndt Borkhardt, Katharina L. Gössling

    Published 2021-09-01
    Get full text
    Article
  6. 6
    The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS.

    The cell cycle regulator CCDC6 is a key target of RNA-binding protein EWS. by Sujitha Duggimpudi, Erik Larsson, Schafiq Nabhani, Arndt Borkhardt, Jessica I Hoell

    Published 2015-01-01
    Get full text
    Article
  7. 7
    Survival in Children Below the Age of 15 Years With Leukemia: Temporal Patterns in Eastern and Western Germany Since German Reunification

    Survival in Children Below the Age of 15 Years With Leukemia: Temporal Patterns in Eastern and Western Germany Since German Reunification by Maike Wellbrock, Hajo Zeeb, Claudia Spix, Desiree Grabow, Arndt Borkhardt, Friederike Erdmann

    Published 2022-08-01
    Get full text
    Article
  8. 8
    Arenaviruses: Old viruses present new solutions for cancer therapy

    Arenaviruses: Old viruses present new solutions for cancer therapy by Paweł Stachura, Paweł Stachura, Olivia Stencel, Zhe Lu, Arndt Borkhardt, Aleksandra A. Pandyra

    Published 2023-03-01
    Get full text
    Article
  9. 9
    Challenges of palliative care in children with inborn metabolic diseases

    Challenges of palliative care in children with inborn metabolic diseases by Jessica I. Hoell, Jens Warfsmann, Felix Distelmaier, Arndt Borkhardt, Gisela Janßen, Michaela Kuhlen

    Published 2018-07-01
    Get full text
    Article
  10. 10
    Accurate and scalable variant calling from single cell DNA sequencing data with ProSolo

    Accurate and scalable variant calling from single cell DNA sequencing data with ProSolo by David Lähnemann, Johannes Köster, Ute Fischer, Arndt Borkhardt, Alice C. McHardy, Alexander Schönhuth

    Published 2021-11-01
    Get full text
    Article
  11. 11
    Non-Pathogenic Heterozygous Polymorphism in RAB27A Gene in a Case Suspicious to Griscelli Syndrome, Type II

    Non-Pathogenic Heterozygous Polymorphism in RAB27A Gene in a Case Suspicious to Griscelli Syndrome, Type II by Aziz Eghbali, Farzaneh Rahmani, Zahra Aryan, Arndt Borkhardt, Parin Tanzifi, Samaneh Zoghi, Nima Rezaei

    Published 2018-11-01
    Get full text
    Article
  12. 12
    Development of the first geldanamycin-based HSP90 degraders

    Development of the first geldanamycin-based HSP90 degraders by Silas Wurnig, Melina Vogt, Julian Hogenkamp, Niklas Dienstbier, Arndt Borkhardt, Sanil Bhatia, Finn K. Hansen

    Published 2023-06-01
    Get full text
    Article
  13. 13
    T-cell leukemogenesis is an inappropriate lineage decision-making process: implications for precision oncology

    T-cell leukemogenesis is an inappropriate lineage decision-making process: implications for precision oncology by Guillermo Rodríguez-Hernández, Sanil Bhatia, Carolina Vicente-Dueñas, Arndt Borkhardt, Julia Hauer, Isidro Sánchez-García

    Published 2018-07-01
    Get full text
    Article
  14. 14
    Second-look surgery after pediatric brain tumor resection – Single center analysis of morbidity and volumetric efficacy

    Second-look surgery after pediatric brain tumor resection – Single center analysis of morbidity and volumetric efficacy by Ann Kristin Schmitz, Christopher Munoz-Bendix, Marc Remke, Triantafyllia Brozou, Arndt Borkhardt, Daniel Hänggi, Thomas Beez

    Published 2022-01-01
    Get full text
    Article
  15. 15
    Senescent Tumor CD8<sup>+</sup> T Cells: Mechanisms of Induction and Challenges to Immunotherapy

    Senescent Tumor CD8<sup>+</sup> T Cells: Mechanisms of Induction and Challenges to Immunotherapy by Wei Liu, Paweł Stachura, Haifeng C. Xu, Sanil Bhatia, Arndt Borkhardt, Philipp A. Lang, Aleksandra A. Pandyra

    Published 2020-09-01
    Get full text
    Article
  16. 16
    Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL), a new method to detect translocations in leukemia.

    Genomic inverse PCR for exploration of ligated breakpoints (GIPFEL), a new method to detect translocations in leukemia. by Elisa Fueller, Daniel Schaefer, Ute Fischer, Pina F I Krell, Martin Stanulla, Arndt Borkhardt, Robert K Slany

    Published 2014-01-01
    Get full text
    Article
  17. 17
    MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways.

    MicroRNAs distinguish cytogenetic subgroups in pediatric AML and contribute to complex regulatory networks in AML-relevant pathways. by Svenja Daschkey, Silja Röttgers, Anamika Giri, Jutta Bradtke, Andrea Teigler-Schlegel, Gunter Meister, Arndt Borkhardt, Pablo Landgraf

    Published 2013-01-01
    Get full text
    Article
  18. 18
    Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?

    Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight? by Sujal Ghosh, Ingo Drexler, Sanil Bhatia, Heiko Adler, Heiko Adler, Heiko Adler, Andrew R. Gennery, Arndt Borkhardt

    Published 2018-05-01
    Get full text
    Article
  19. 19
    Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight?

    Corrigendum: Interleukin-2-Inducible T-Cell Kinase Deficiency—New Patients, New Insight? by Sujal Ghosh, Ingo Drexler, Sanil Bhatia, Heiko Adler, Heiko Adler, Heiko Adler, Andrew R. Gennery, Arndt Borkhardt

    Published 2018-10-01
    Get full text
    Article
  20. 20
    Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies

    Resolving inherited and de novo germline predisposing sequence variants by means of whole exome trio analyses in childhood hematological malignancies by Triantafyllia Brozou, Layal Yasin, Danielle Brandes, Daniel Picard, Carolin Walter, Julian Varghese, Martin Dugas, Ute Fischer, Arndt Borkhardt, Oskar A. Haas

    Published 2023-02-01
    Get full text
    Article

Search Tools: